Oncology Institute Inc

NASDAQ:TOIUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. It also provides management services to 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Contact Information

Headquarters

18000 Studebaker Rd, Suite 800CERRITOS, CA, United States 90703

Phone

562-735-3226

Fax

302-636-5454

Executives

Director

Richard Barasch

Chief Executive Officer, Director

Daniel Virnich

Independent Vice Chairman of the Board

Brad Hively

Chief Financial Officer

Mihir Shah

Chief Operating Officer

Jeremy Castle